Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matko Kalac

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 2, 2020
Acute cardiomyopathy following a single dose of doxorubicin in a patient with adult T-Cell leukemia/lymphomaKyle Farina, Matko Kalac, Sara Kim
Blood|April 24, 2024
Current and upcoming treatment approaches to uncommon subtypes of PTCL (EATL, MEITL, SPTCL, and HSTCL)Enrica Marchi, Jeffrey W Craig, Matko Kalac
Current Hematologic Malignancy Reports|July 24, 2017
An Update on the Use of Immunotherapy in the Treatment of LymphomaThomas U Marron, Matko Kalac, Joshua Brody
BMJ Case Reports|August 29, 2023
Idiopathic CD4+ T-lymphocytopaenia with <i>FLT1</i> mutation complicated by progressive multifocal leucoencephalopathy and EBV+ polymorphic lymphoproliferative disorderNoa Rippel, Joshua Wong, Shafinaz Hussein, et al.
Acta Medica Croatica : Casopis Hravatske Akademije Medicinskih Znanosti|October 16, 2009
[Autologous stem cell transplantation in patients with relapsed or refractory Hodgkin's disease]Hrvoje Minigo, Radovan Vrhovac, Matko Kalac, et al.
Cureus|October 4, 2023
CD19-Targeted Chimeric Antigen Receptor T-cell Therapy for Concomitant Diffuse Large B-cell Lymphoma and Multiple MyelomaTyler D'Ovidio, Kathryn Ciccolini, Matko Kalac, et al.
Cancer|July 27, 2007
A critical appraisal of conventional and investigational drug therapy in patients with hypereosinophilic syndrome and clonal eosinophiliaMatko Kalac, Alfonso Quintás-Cardama, Radovan Vrhovac, et al.
Hematology/Oncology Clinics of North America|October 29, 2008
New drugs for the treatment of lymphomaLuca Paoluzzi, Yukiko Kitagawa, Matko Kalac, et al.
Lijecnicki Vjesnik|July 1, 2006
[Microcellular lung carcinoma in patient with hepatosplenic T-cell lymphoma: a case report]Matko Kalac, Slobodanka Ostojić, Slavko Gasparov, et al.
Journal of Cancer Science & Therapy|January 28, 2014
Propolis and its Active Component, Caffeic Acid Phenethyl Ester (CAPE), Modulate Breast Cancer Therapeutic Targets via an Epigenetically Mediated Mechanism of ActionCoral Omene, Matko Kalac, Jing Wu, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 2, 2020
Acute cardiomyopathy following a single dose of doxorubicin in a patient with adult T-Cell leukemia/lymphomaKyle Farina, Matko Kalac, Sara Kim
Blood|April 24, 2024
Current and upcoming treatment approaches to uncommon subtypes of PTCL (EATL, MEITL, SPTCL, and HSTCL)Enrica Marchi, Jeffrey W Craig, Matko Kalac
Current Hematologic Malignancy Reports|July 24, 2017
An Update on the Use of Immunotherapy in the Treatment of LymphomaThomas U Marron, Matko Kalac, Joshua Brody
BMJ Case Reports|August 29, 2023
Idiopathic CD4+ T-lymphocytopaenia with <i>FLT1</i> mutation complicated by progressive multifocal leucoencephalopathy and EBV+ polymorphic lymphoproliferative disorderNoa Rippel, Joshua Wong, Shafinaz Hussein, et al.
Acta Medica Croatica : Casopis Hravatske Akademije Medicinskih Znanosti|October 16, 2009
[Autologous stem cell transplantation in patients with relapsed or refractory Hodgkin's disease]Hrvoje Minigo, Radovan Vrhovac, Matko Kalac, et al.
Cureus|October 4, 2023
CD19-Targeted Chimeric Antigen Receptor T-cell Therapy for Concomitant Diffuse Large B-cell Lymphoma and Multiple MyelomaTyler D'Ovidio, Kathryn Ciccolini, Matko Kalac, et al.
Cancer|July 27, 2007
A critical appraisal of conventional and investigational drug therapy in patients with hypereosinophilic syndrome and clonal eosinophiliaMatko Kalac, Alfonso Quintás-Cardama, Radovan Vrhovac, et al.
Hematology/Oncology Clinics of North America|October 29, 2008
New drugs for the treatment of lymphomaLuca Paoluzzi, Yukiko Kitagawa, Matko Kalac, et al.
Lijecnicki Vjesnik|July 1, 2006
[Microcellular lung carcinoma in patient with hepatosplenic T-cell lymphoma: a case report]Matko Kalac, Slobodanka Ostojić, Slavko Gasparov, et al.
Journal of Cancer Science & Therapy|January 28, 2014
Propolis and its Active Component, Caffeic Acid Phenethyl Ester (CAPE), Modulate Breast Cancer Therapeutic Targets via an Epigenetically Mediated Mechanism of ActionCoral Omene, Matko Kalac, Jing Wu, et al.
Pageof 3